Biomedicines (Dec 2022)

Impact of Adenomyosis on Infertile Patients—Therapy Options and Reproductive Outcomes

  • Veronika Günther,
  • Leila Allahqoli,
  • Georgios Gitas,
  • Nicolai Maass,
  • Karolin Tesch,
  • Johannes Ackermann,
  • Paula Rosam,
  • Liselotte Mettler,
  • Sören von Otte,
  • Ibrahim Alkatout

DOI
https://doi.org/10.3390/biomedicines10123245
Journal volume & issue
Vol. 10, no. 12
p. 3245

Abstract

Read online

Adenomyosis is associated with a negative impact on reproductive outcomes. Although adenomyosis is detected more frequently in women of late reproductive age, its impact on pregnancy rates is important because, in today’s world, family planning has shifted towards the late reproductive phase of life for many women. Although the diagnostic indications for imaging studies are well-known, we lack strict diagnostic criteria and classification systems concerning the extent of the disease. Selecting the optimal evidence-based treatment option for adenomyosis is difficult because of the paucity of evidence concerning the association between fertility and the degree and composition of adenomyosis. Furthermore, the treatment of infertility might interfere with the treatment of adenomyosis due to the presence of pain. The aim of this review is to analyze the association between adenomyosis and infertility, and describe treatment options to enhance reproductive outcomes. The following aspects will be addressed in detail: (a) prevalence and causes of adenomyosis, (b) diagnostic tools with imaging techniques, (c) clinical symptoms, (d) proposed pathomechanism of adenomyosis and infertility, and (e) different treatment approaches (pharmacological, surgical, others) and their impact on reproductive outcomes.

Keywords